echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The second wave of the new crown outbreak is coming! Emergency withdrawal after CDC releases new anti-epidemic guidelines?

    The second wave of the new crown outbreak is coming! Emergency withdrawal after CDC releases new anti-epidemic guidelines?

    • Last Update: 2020-10-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Text . . . Forest just when we thought that the vaccine was about to go on sale, the outbreak is nearing the end, recently, Shanghai Jiaojiao University, the second "Antai Symphony" summit forum, Zhang Wenhong director said that France, Spain and other countries have appeared a second wave of outbreaks, the second wave of outbreaks is inevitable.
    According to the figures, france's single-day cases, more than 13,000 in a row, a total of 440,000 confirmed cases, Spain's one-day surge of 14,000 cases, a record-breaking total of 640,000 confirmed cases, Madrid has become the focus, some areas may have to restart restrictions.
    bad news yesterday, with 4,400 new cases added on Saturday and nearly 3,900 more on Sunday.
    number of new cases in the U.S. has climbed again in recent days, with the death toll approaching 200,000.
    It is possible that the outbreak in China has been controlled, many people are no longer concerned about the outbreak, because the vaccine has come out, these outbreaks will pass sooner or later, but did not expect the virus is really very tenacious, in the last gap period, is still in the wind and waves.
    other countries, with the exception of China, are basically waiting for a vaccine, but recent progress has not been so smooth.
    the re-launch of AstraZeneta's new crown vaccine, and on September 21st AstraZeneta released details of human trials of the COVID-19 vaccine.
    . Americans are increasingly skeptical of the COVID-19 vaccine, and experts fear it could lead to premature approval of unproven vaccines because of Pressure from Mr. Trump, the New York Times reported.
    reported that AstraZeneta's new crown vaccine has two cases of severe neurological disease, the first case is transverse spinal corditis, the second case has yet to be confirmed.
    as a result of these adverse reactions, AstraZeneta suspended the trial twice.
    is currently on hold in the US, but has been restarted in the UK, Brazil, India and South Africa.
    the new vaccine has been strongly questioned by the scientific community several times because AstraZeneta has refused to provide details of adverse reactions in both cases.
    agreement, released over the weekend, AstraZeneta promised to develop a new coronavirus vaccine that would be 50 percent effective, a basic requirement of the FDA's COVID-19 vaccine guidelines.
    , Moderna and Pfizer have also released information about clinical trials of their COVID-19 vaccine candidates.
    Pfizer's New Crown Vaccine Phase 3 clinical trial also showed some adverse reactions, including fatigue, headache, chills, muscle pain, fever and other symptoms, and some volunteers developed high fever.
    current U.S. poll has shown that 40 percent of Americans are reluctant to get vaccinated, even if it's free, after the new vaccine is available.
    and public trust are key to ending the outbreak and returning to normal life, and people don't trust the vaccine and they will refuse it.
    The U.S. Centers for Disease Control and Prevention issued new anti-epidemic guidelines and then urgently withdrew September 18, the U.S. Centers for Disease Control and Prevention of new coronary pneumonia guidelines updated, the new coronavirus can be transmitted through fine particles in the air, and the spread distance can be more than 6 feet.
    , the CDC recommends using air purifiers at home to reduce viruses in the air.
    the U.S. Centers for Disease Control and Prevention said on the 21st that the content of the update is wrong, has now deleted the "wrong draft", and said the new epidemic prevention guidelines will be revised after the completion of the re-release.
    , the CDC did not recommend any new measures to reduce the threat of air-borne transmission of the new coronavirus, but experts said the removal of the guidelines could lead to changes in public behavior and policy.
    is a "major change" for the CDC, says Dr Jimenez of the University of Colorado.
    " outbreak of the second outbreak, Europe and the United States panic, China's situation is different outbreak, but also reflected in the stock market, yesterday's European stock market crash, the German stock market fell 4.4%, France and the United Kingdom index also fell more than 3%, the European plunge led the U.S. stock market opened also fell sharply, the S.P. 500 also fell more than 2.5%, but good at the last minute closed back, the U.S. stock market falsely.
    china's current anti-epidemic strategy is proactive defense strategy, while other countries have difficulty controlling the outbreak, can only wait for the vaccine, but the vaccine will take time.
    vaccine is currently in Phase III clinical trials, but it will take time for the trials to be completed and put into production and shipping.
    europe and the United States productivity has also been seriously affected by the outbreak, demand is large, so some experts decided that Europe and the United States completely brought down the outbreak, at least a year.
    and China has a clear advantage, because our vaccine development itself is very fast, it was announced that november-December will be available, production capacity is also in preparation.
    So the progress of research and development is one thing, production is another, research and development is now in step with each other, between Bo Zhong, but if production starts, it is estimated that it is the time to witness the Miracle of China.
    we are likely to create an advantage in the production and paving sectors.
    source 1.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.